RXI Pharmaceuticals' (RXII) CEO Dr. Geert Cauwenbergh on Q3 2016 Results - Earnings Call Transcript

11/11/16

RXI Pharmaceuticals Corporation (NASDAQ:RXII)

Q3 2016 Earnings Conference Call

November 10, 2016 4:30 PM ET

Executives

Tamara McGrillen - Investor Relations

Dr. Geert Cauwenbergh - Chief Development Officer

Dr. Pamela Pavco - President & Chief Executive Officer

Caitlin Kontulis - Principal Accounting Officer

Analysts

Operator

Good afternoon ladies and gentlemen, and welcome to the RXi Pharmaceuticals’ Third Quarter 2016 Earnings Conference Call. Today’s call is being recorded.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.